Cardiff Oncology's total assets for Q4 2024 were $97.19M, an increase of 54.52% from the previous quarter. DE:XE7C total liabilities were $14.24M for the fiscal quarter, a 5.46% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.